Your browser doesn't support javascript.
loading
The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptic drugs.
Frey, Noel; Bodmer, Michael; Bircher, Andreas; Rüegg, Stephan; Jick, Susan S; Meier, Christoph R; Spoendlin, Julia.
Affiliation
  • Frey N; Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacy and Epidemiology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.
  • Bodmer M; Hospital Pharmacy, University Hospital Basel, Basel, Switzerland.
  • Bircher A; Internal Medicine, Cantonal Hospital Zug, Basel, Switzerland.
  • Rüegg S; Allergology, University Hospital Basel, Basel, Switzerland.
  • Jick SS; Division of Clinical Neurophysiology, University Hospital Basel, Basel, Switzerland.
  • Meier CR; Boston Collaborative Drug Surveillance Program, Boston University, Lexington, Massachusetts, U.S.A.
  • Spoendlin J; Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacy and Epidemiology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.
Epilepsia ; 58(12): 2178-2185, 2017 12.
Article in En | MEDLINE | ID: mdl-29027197

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stevens-Johnson Syndrome / Drug Eruptions / Anticonvulsants Type of study: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male Language: En Journal: Epilepsia Year: 2017 Document type: Article Affiliation country: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stevens-Johnson Syndrome / Drug Eruptions / Anticonvulsants Type of study: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male Language: En Journal: Epilepsia Year: 2017 Document type: Article Affiliation country: Switzerland